Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20 - du Bois, A; Vergote, I; Ferron, G (J Clin Oncol, 2017)